elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38857067-2F7203D8-9AAB-4649-B49D-6B62069FCF81
Q38857067-2F7203D8-9AAB-4649-B49D-6B62069FCF81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-2F7203D8-9AAB-4649-B49D-6B62069FCF81
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
P356
Q38857067-2F7203D8-9AAB-4649-B49D-6B62069FCF81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-2F7203D8-9AAB-4649-B49D-6B62069FCF81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba48a87575df746b335220ef14fe310f4082e9c2
P356
10.1038/LEU.2015.175
http://www.w3.org/2001/XMLSchema#string
P356
LEU.2015.175